Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience

Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience

Objective Antimicrotubular agents are among the most commonly used classes of chemotherapeutic agents, but the risk of cardiovascular adverse events (CVAEs) remains unclear. Our objective was to study the CVAEs associated with antimicrotubular agents.Methods The Food and Drug Administration’s Advers...

Full description

Bibliographic Details
Main Authors: Avirup Guha, Sarju Ganatra, Brijesh Patel, Daniel Addison, Anita Deswal, Sherry-Ann Brown, Michael Fradley, Akshee Batra, Lauren A Baldassarre, Nihar Desai, Neal Weintraub, Zeeshan Hussain, Vivek Agarwala, Purvish M Parikh, Arjun Ghosh
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/8/2/e001849.full

Internet

https://openheart.bmj.com/content/8/2/e001849.full

Similar Items